ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,410.01
0.11%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Alvontech (ALVO) Share Price

ALVO Alvontech

14.04
0.05 (0.36%)
07 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Alvontech NASDAQ:ALVO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.05 0.36 14.04 12.05 15.15 14.14 13.965 14.07 144,393 21:14:33   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Coml Physical, Biologcl Resh 93.38M -551.73M -2.0938 -6.72 3.7B
 Type  Size  Price  Time  Units 
 20 3,445 14.04 20:00:32 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALVO News
07/06/202409:00GLOBEAlvotech Announces Strategic Refinancing Agreement
29/05/202413:05GLOBEAlvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
21/05/202422:15GLOBEAlvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
21/05/202415:05BWAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
21/05/202413:00GLOBEAlvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
21/05/202412:13IHMARKETNEWSU.S. Index Futures Open Lower Amid Nasdaq Record, Fed Speeches
21/05/202401:25GLOBETeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Period
Draw mode
Data Downloads for ALVO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Alvontech Articles